Leerink Swann reaffirms Stryker's 'outperform' rating — 5 notes

Spinal Tech

Leerink Swann analysts reaffirmed Stryker stock's "outperform" rating, according to the Legacy.

Here are five notes:

 

1. Leerink Swann gave Stryker stock a target price of $110.

 

2. Leerink Swann projects a potential upside of 8.3 percent from Stryker's previous close.

 

3. Stryker shares traded up 0.01 percent on Monday, hitting $101.62.

 

4. Stryker has a one year low of $77.87 and a one year high of $103.99.

 

5. The company has a market cap of $38.3 billion and a P/E ratio of 41.7.

 

More articles on devices:
Nevro announces positive results from SENZA system study: 5 insights
Smith & Nephew to build US headquarters in Fort Worth: 5 things to know
Is Stryker next for a big transaction? 7 key notes

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers